PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)
$99.98 0.79 (0.7965%)
Analysed PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) News Sources
Protagonist Therapeutics Inc. (PTGX): Billionaire Joe Edelman Likes This Stock
27-04-2026
yahoo.com
Protagonist Exercises Rusfertide U.S. Opt-Out Right Under Takeda Collaboration
28-04-2026
yahoo.com
Protagonist Therapeutics Inc. (PTGX): Billionaire Tom Steyer Likes Upside Potential of This Stock
02-05-2026
yahoo.com
Protagonist Reports First Quarter 2026 Financial Results and Provides Corporate Update
05-05-2026
yahoo.com
Is It Too Late To Consider Protagonist Therapeutics (PTGX) After Its 141% One Year Surge?
07-05-2026
yahoo.com
Protagonist Therapeutics, Inc. Surprised Analysts With A Profit, And Analysts Boosted Their EPS Forecasts
08-05-2026
yahoo.com
Analyst Forecasts For Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Are Surging Higher
11-05-2026
yahoo.com
Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?
18-05-2026
fool.com
Hedge Fund Drops $40 Million on Gene-Editing Biotech Beam. Is It a Buy?
18-05-2026
fool.com
Hedge Fund Wagers $36 Million on Biotech Denali After First FDA Approval
18-05-2026
fool.com
What is the current price of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)?
The current price of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) is $99.98.
PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) since the previous trading day is $0.79.
PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) since the previous trading day is 0.7965%.
What is the most recent average sentiment score for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)?
The most recent average sentiment score for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)?
The most recent sentiment for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) is .
SEC-8K** Filing Available For PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.